Sponsored Opening doors to immunotherapy in prostate cancer: A roadmap from clinic to community January 23, 2026Vol.52 No.03By Tanya Dorff
FreeIn the Archives Bernie Lewinsky’s collection of artifacts captures “the learning curve” of radiation oncology January 23, 2026Vol.52 No.03By Sara Willa Ernst
News Analysis ACS report trumpets 70% five-year survival for all cancers amid uncertain funding outlook January 16, 2026Vol.52 No.02By Jacquelyn Cobb and Paul Goldberg
Health Equity New Medicaid work requirements could lead to 1.6 million missed cancer screenings over two years January 16, 2026Vol.52 No.02By Sara Willa Ernst
FreeGuest Editorial When “safe and effective” is not “reasonable and necessary”We can curb excessive drug dosing and improve the quality of cancer care January 16, 2026Vol.52 No.02By Mark J. Ratain and David A. Hyman
Trials & Tribulations A radiation oncologist’s perspective: Why we need to accelerate early detection strategies for lung cancers January 16, 2026Vol.52 No.02By Kevin King
FreeObituary Ben Seon, immunologist whose work led to development of lymphoma drug Polivy, dies at 89 January 16, 2026Vol.52 No.02By Roswell Park Comprehensive Cancer Center
A planned randomized trial will ask an intriguing question: Do COVID vaccines potentiate checkpoint inhibitors? January 09, 2026Vol.52 No.1By Sara Willa Ernst and Jacquelyn Cobb
Trials & Tribulations How a Montefiore Einstein screening program is changing the history of lung cancer in the Bronx January 09, 2026Vol.52 No.1By Brendon M. Stiles
FreeObituary MSK’s AML researcher Bayard “Barney” Clarkson, former president of ASCO and AACR, dies at 99 January 09, 2026Vol.52 No.1By Paul Goldberg
